Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US6646001B2 · kind B2 · utility
62Cited by
27References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2002 |
| Grant date | Nov 11, 2003 |
| Priority date | — |
| Expiry date | Feb 20, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/215
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods and compositions for the treatment of glaucoma and ocular hypertension, comprising the administration of a prostaglandin FP receptor agonist and a prostaglandin synthesis inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.